Poland · Delayed Price · Currency is PLN Dr.Finance Statistics
Total Valuation
Dr.Finance has a market cap or net worth of PLN 5.65 million. The enterprise value is 5.59 million.
| Market Cap | 5.65M |
| Enterprise Value | 5.59M |
Important Dates
The last earnings date was Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Dr.Finance has 3.74 million shares outstanding.
| Current Share Class | 3.74M |
| Shares Outstanding | 3.74M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 88.91% |
| Owned by Institutions (%) | n/a |
| Float | 208,198 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.91 |
| PB Ratio | 200.97 |
| P/TBV Ratio | 200.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.82
| Current Ratio | 1.82 |
| Quick Ratio | 1.76 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,465.05 |
Financial Efficiency
Return on equity (ROE) is -172.66% and return on invested capital (ROIC) is -1,863.08%.
| Return on Equity (ROE) | -172.66% |
| Return on Assets (ROA) | -72.68% |
| Return on Invested Capital (ROIC) | -1,863.08% |
| Return on Capital Employed (ROCE) | -1,307.09% |
| Weighted Average Cost of Capital (WACC) | 14.21% |
| Revenue Per Employee | 356,844 |
| Profits Per Employee | -150,647 |
| Employee Count | 2 |
| Asset Turnover | 2.26 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Dr.Finance has paid 1,513 in taxes.
| Income Tax | 1,513 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +101.33% in the last 52 weeks. The beta is 1.81, so Dr.Finance's price volatility has been higher than the market average.
| Beta (5Y) | 1.81 |
| 52-Week Price Change | +101.33% |
| 50-Day Moving Average | 1.20 |
| 200-Day Moving Average | 1.51 |
| Relative Strength Index (RSI) | 69.96 |
| Average Volume (20 Days) | 7,434 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr.Finance had revenue of PLN 713,687 and -301,293 in losses. Loss per share was -0.08.
| Revenue | 713,687 |
| Gross Profit | 663,439 |
| Operating Income | -367,292 |
| Pretax Income | -299,780 |
| Net Income | -301,293 |
| EBITDA | -366,790 |
| EBIT | -367,292 |
| Loss Per Share | -0.08 |
Balance Sheet
The company has 59,500 in cash and no debt, with a net cash position of 59,500 or 0.02 per share.
| Cash & Cash Equivalents | 59,500 |
| Total Debt | n/a |
| Net Cash | 59,500 |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 28,100 |
| Book Value Per Share | 0.01 |
| Working Capital | 28,100 |
Cash Flow
| Operating Cash Flow | -324,455 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 502 |
| Net Borrowing | 1,300 |
| Free Cash Flow | -324,455 |
| FCF Per Share | -0.09 |
Margins
Gross margin is 92.96%, with operating and profit margins of -51.46% and -42.22%.
| Gross Margin | 92.96% |
| Operating Margin | -51.46% |
| Pretax Margin | -42.00% |
| Profit Margin | -42.22% |
| EBITDA Margin | -51.39% |
| EBIT Margin | -51.46% |
| FCF Margin | n/a |
Dividends & Yields
Dr.Finance does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -5.34% |
| FCF Yield | -5.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 1, 2016. It was a reverse split with a ratio of 0.01.
| Last Split Date | Jul 1, 2016 |
| Split Type | Reverse |
| Split Ratio | 0.01 |
Scores
Dr.Finance has an Altman Z-Score of 5.82.
| Altman Z-Score | 5.82 |
| Piotroski F-Score | n/a |